DeepMind Expands AlphaFold Beyond Proteins to Model Full Biological Systems
Google DeepMind releases AlphaFold 3, an upgraded AI tool that predicts the structures and interactions of DNA, RNA, and ligands. This breakthrough promises to significantly accelerate early-stage drug discovery and broader biological research.
Google DeepMind releases AlphaFold 3, an upgraded artificial intelligence tool that predicts the structures of DNA, RNA, and other molecules rather than just proteins. This advancement gives scientists a more dynamic portrait of how different molecules interact within biological systems. The tool builds on the success of the 2020 version by addressing a major demand from the research community to model a much larger slice of biological life.
The new capabilities make AlphaFold 3 significantly more useful for the pharmaceutical industry. Because the system now understands ligands, researchers can predict exactly where a drug binds to a protein. Isomorphic Labs, a DeepMind drug discovery spinoff, already uses this model to collaborate with pharmaceutical companies on developing new disease treatments.
While the full impact of AlphaFold 3 remains to be seen, experts consider it a massive leap forward for early-stage research. Previous iterations of the technology help map the human heart and model antimicrobial resistance, and this broader approach opens fresh possibilities for identifying everything from resilient crops to new vaccines.